Related Experiment Video

Updated: Jan 20, 2026

Culturing Primary Rat Inner Medullary Collecting Duct Cells
06:11

Culturing Primary Rat Inner Medullary Collecting Duct Cells

Published on: June 21, 2013

15.2K

Collecting ducts carcinoma: An orphan disease. Literature overview and future perspectives

Filippo Pagani1, Maurizio Colecchia2, Pierangela Sepe1

  • 1Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Cancer Treatment Reviews
|September 7, 2019
PubMed

Insights

Collecting duct carcinoma (CDC) is a rare, aggressive kidney cancer. Current platinum and gemcitabine chemotherapy offers limited survival benefits, necessitating research into novel treatments.

Area of Science:

  • Oncology
  • Urology
  • Genitourinary Pathology

Background:

  • Collecting duct carcinoma (CDC) is a rare and aggressive subtype of renal cell carcinoma.
  • It represents approximately 1% of all kidney tumors.
  • Patients often present with advanced disease and metastasis, leading to poor clinical conditions.

Observation:

  • Limited data from prospective trials exist due to the rarity of CDC.
  • The median overall survival for metastatic CDC is approximately 11 months.
  • Current standard treatment, platinum and gemcitabine chemotherapy, yields unsatisfactory survival outcomes.

Findings:

  • The review synthesizes current literature on managing this rare cancer.
  • It highlights the urgent need for improved therapeutic strategies.
  • Growing interest in understanding CDC biology may reveal new treatment targets.

Implications:

  • There is a critical need for novel, biologically-driven treatment approaches for collecting duct carcinoma.
  • Further research into the underlying biology of CDC is essential for developing more effective therapies.
  • Improved management strategies are required to enhance survival outcomes for patients with this aggressive malignancy.
Keywords:
Bellini diseaseChemotherapyCollecting ducts carcinomaImmunotherapyRenal cell carcinomaTargeted therapy

More Related Videos

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease04:11

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease

Published on: April 28, 2023

2.5K
Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

3.2K

Related Concept Videos

Renal Tubule and Collecting Duct01:24

Renal Tubule and Collecting Duct

The renal tubule is divided into three parts: the proximal convoluted tubule (PCT), the Loop of Henle (LOH), and the distal convoluted tubule (DCT).
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...
3.2K
Reabsorption and Secretion in the DCT and Collecting Duct01:26

Reabsorption and Secretion in the DCT and Collecting Duct

The early phase of the DCT manages the reabsorption of approximately 10-15% of filtered water, 5–10% of filtered sodium, and 5–10% of filtered chloride. This process is facilitated by Na+–Cl− symporters in apical membranes and sodium-potassium pumps, as well as Cl− leakage channels in basolateral membranes. The early DCT also stands out as a site where parathyroid hormone (PTH) stimulates calcium reabsorption, depending on the body's requirements.
The distal...
3.0K
Culturing Primary Rat Inner Medullary Collecting Duct Cells06:11

Culturing Primary Rat Inner Medullary Collecting Duct Cells

Arginine-vasopressin (AVP) controls fine-tuning of body water homeostasis through facilitating water reabsorption by renal principal cells. Here, we present a protocol for the cultivation of primary rat inner medullary collecting duct cells suitable for the elucidation of molecular mechanisms underlying AVP-mediated water...
15.2K
Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease04:11

Endolymphatic Duct Blockage as a Surgical Treatment Option for Ménière's Disease

Endolymphatic duct blockage is a relatively new surgical method for patients suffering from Ménière's disease. Following a regular mastoidectomy, the endolymphatic duct is identified and ligated using a regular titanium hemoclip. The effectiveness of this procedure is currently being assessed in a randomized trial.
2.5K
An Overview of Genetics and Disease10:47

An Overview of Genetics and Disease

Many human diseases are associated with mutations or variations in genetic sequences. Some of these genetic variants are heritable, passed down from generation to generation, while others arise sporadically during an organism’s life and cause diseases such as cancer. Researchers are trying to identify and characterize these genetic alterations in the hopes of improving diagnosis and therapeutic options for patients.In this video, we will examine the history of genetic disease research,...
55.5K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K